| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Third Harmonic Bio, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 136K | 06 Mar 2023 | Direct | ||
| Neoleukin Therapeutics, Inc. | Chief Financial Officer | Restricted Stock Units | 70K | 01 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| THRD | Third Harmonic Bio, Inc. | 06 Mar 2023 | 5 | $0 | 4 | Chief Financial Officer | 08 Mar 2023, 15:58 |
| THRD | Third Harmonic Bio, Inc. | 25 Oct 2022 | 1 | $0 | 4 | Chief Financial Officer | 27 Oct 2022, 16:51 |
| THRD | Third Harmonic Bio, Inc. | 14 Sep 2022 | 0 | $0 | 3 | Chief Financial Officer | 14 Sep 2022, 18:11 |
| NLTX | Neoleukin Therapeutics, Inc. | 01 Feb 2022 | 1 | $0 | 4 | Chief Financial Officer | 02 Feb 2022, 15:36 |
| NLTX | Neoleukin Therapeutics, Inc. | 03 Aug 2021 | 1 | $0 | 4 | Chief Financial Officer | 05 Aug 2021, 16:14 |